COVID-19 Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0JL1M
|
|||
Drug Name |
Thiethylperazine
|
|||
Synonyms |
ETHYLTHIOPERAZINE; Theithylperazine; Thiethylperazinum; Thiethylpipezazine; Thioethylperazine; Tietilperazina; Torecan; Tietilperazina [DCIT]; Thiethylperazinum [INN-Latin]; Torecan (TN); Thiethylperazine (USAN/INN); Thiethylperazine [USAN:INN:BAN]; Norzine (*Dimaleate*); GS-95 (*Dimaleate*)
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Middle East Respiratory Syndrome (MERS) | Investigative | [1] | |
Therapeutic Class |
Antiviral Agents
|
|||
Company |
Norvatis Phamaceuticals Corporation
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H29N3S2
|
|||
Canonical SMILES |
CCSC1=CC2=C(C=C1)SC3=CC=CC=C3N2CCCN4CCN(CC4)C
|
|||
InChI |
1S/C22H29N3S2/c1-3-26-18-9-10-22-20(17-18)25(19-7-4-5-8-21(19)27-22)12-6-11-24-15-13-23(2)14-16-24/h4-5,7-10,17H,3,6,11-16H2,1-2H3
|
|||
InChIKey |
XCTYLCDETUVOIP-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 1420-55-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
9342, 618292, 5646731, 7849413, 7980773, 8153348, 10507857, 14879091, 29224490, 46506502, 48416610, 49699402, 50006536, 56352874, 57322781, 76368511, 85209578, 103462495, 104309248, 125089234, 125823178, 127339724, 127339725, 127339726, 134222490, 134337627, 134979014, 135739860, 137001505, 142971091, 160963719, 162939803, 178103879, 179116916, 184527123, 198985013, 226432954, 249932754, 251971089, 252655192
|
|||
ChEBI ID |
CHEBI:9544
|
Target | Top | |||
---|---|---|---|---|
Target(s) | HUMAN clathrin-mediated endocytosis (RME) | Target Info | Inhibitor | [1] |
Thiethylperazine exhibits inhibitory activity against clathrin-mediated endocytosis of MERS-CoV with EC50s of 7.86 microM. |
References | Top | |||
---|---|---|---|---|
1 | Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014 Aug;58(8):4885-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.